Over 1 billion people worldwide live with conditions that stem cell therapy is actively being researched to help. If your body is fighting itself, breaking down faster than it can repair, or struggling to heal — stem cells address the root cause. Scroll through every category below to find your situation.
Your immune system attacks the lining of your joints, causing constant pain, swelling, and eventual joint destruction. Standard drugs suppress your entire immune system — opening you to infections. MSCs reduce the specific immune cells attacking your joints while repairing cartilage and reducing inflammation locally, without shutting down your whole immune defense.
Joint PainSwellingStiffnessFatigue
Clinical EvidenceGhoryani et al., 2019 — Phase II trial: autologous MSCs significantly reduced disease activity scores (DAS28) in refractory RA patients. Stem Cell Research & Therapy.
Lupus attacks everything — kidneys, heart, brain, skin, joints — because your immune system's B and T cells lose their ability to tell friend from foe. In clinical studies, MSC infusions significantly reduced lupus disease activity scores, and more than half of patients were able to reduce or discontinue their medications after treatment.
Kidney DiseaseRashesFatigueJoint Pain
Clinical EvidenceWang et al., 2021 — 40-patient trial: UC-MSC treatment showed significant reduction in SLE disease activity; over half reduced or discontinued medications. Journal of Experimental Medicine.
MS occurs when your immune system attacks the protective myelin sheath around your nerves — like stripping the insulation from electrical wires. Signals misfire, slow down, or stop entirely. MSCs travel directly to brain lesions, protect existing nerve fibers, and control the immune attack. 70% of MS patients in one Tisch Medical Center trial showed improved disability scores after stem cell treatment.
Nerve DamageMobility IssuesVisionCognitive Fog
Clinical EvidenceTisch MS Research Center, NCT01933802 — 70% of 10 MS patients showed improved disability scores after intrathecal MSC therapy with no chemotherapy. JAMA Neurology.
Inflammatory bowel diseases create chronic inflammation throughout your digestive tract, destroying the gut lining and making it impossible to absorb nutrients properly. 11 out of 18 major human studies confirmed improvement in Crohn's disease activity after stem cell treatment — with cells repairing the mucosal lining and calming the immune attack on the gut.
Gut PainDiarrheaMalnutritionFatigue
2 million Americans live with Post-Treatment Lyme Disease — brain fog, nerve pain, fatigue, and joint damage that antibiotics can't fix because the damage is already done and the immune system is stuck in overdrive. Stem cells reset the immune system, repair nerve and tissue damage, and cross the blood-brain barrier to address neurological Lyme symptoms directly.
Brain FogNerve PainFatigueJoint Damage
Psoriasis is your immune system signaling skin cells to reproduce 10 times faster than normal, creating painful, inflamed plaques. When it attacks the joints too, it becomes psoriatic arthritis. MSCs dramatically reduce the inflammatory signals that trigger these skin cell overproduction cycles — calming flares systemically, not just on the surface.
Skin PlaquesScalingJoint PainItching
In Type 1 diabetes, your immune system attacks and destroys the beta cells in your pancreas that make insulin — forcing lifelong dependence on injections. Stem cells are being researched to both regenerate new insulin-producing cells and, crucially, stop the immune attack that would destroy them again. This is potentially the closest thing to a biological cure being studied today.
Insulin DependenceBlood SugarPancreatic Damage
Clinical EvidenceNeumann et al., 2023 — Journal of Colloid and Interface Science: encapsulated stem cell-derived beta cells show strong promise for restoring insulin production while shielding from autoimmune attack.
Hashimoto's causes your immune system to slowly destroy your thyroid gland (leading to hypothyroidism), while Graves' disease causes it to overstimulate the thyroid. Both leave patients dependent on lifelong medication. MSCs modulate the autoimmune attack on thyroid tissue and have shown potential in reducing thyroid antibody levels and restoring more normal function.
FatigueWeight IssuesBrain FogHeart Palpitations
Sjögren's attacks the glands that produce moisture — your eyes, mouth, and other organs become chronically dry and inflamed. It often comes alongside other autoimmune diseases like lupus or RA. UC-MSC+ stem cells have been clinically used for Sjögren's, reducing the immune attack on moisture-producing glands and improving secretion and quality of life.
Dry EyesDry MouthFatigueJoint Pain
Clinical EvidenceXu et al., 2021 — Multicenter clinical trial: allogeneic MSC infusions improved salivary gland function and systemic disease activity scores in primary Sjögren's syndrome patients. Arthritis & Rheumatology.
Scleroderma causes your immune system to overproduce collagen, literally hardening your skin and internal organs. It can damage the lungs, kidneys, and digestive system. January 2025 research showed umbilical cord MSCs significantly reduced skin thickening in scleroderma models, and autologous stem cell transplants have improved long-term survival in clinical registries.
Skin HardeningRaynaud'sLung FibrosisSwallowing Issues
Clinical EvidenceBlank et al., 2022 — National registry data: autologous HSCT improves long-term survival in systemic sclerosis. January 2025 study confirmed UC-MSCs reduce skin thickening in scleroderma models. Arthritis Research & Therapy.
Myasthenia Gravis occurs when antibodies attack the connection between nerves and muscles — causing muscles to weaken and tire rapidly. Even breathing can become difficult in severe cases. MSCs suppress the antibody-producing B cells responsible for the attack and support nerve-muscle junction repair, offering potential relief from this debilitating condition.
Muscle WeaknessDrooping EyelidsDifficulty Breathing
Clinical EvidenceDanikowski et al., 2017 — Review in Journal of Neuroinflammation: MSC therapy suppresses the antibody-producing B cells and acetylcholine receptor antibodies responsible for neuromuscular junction dysfunction in MG.
When your immune system attacks your liver cells, chronic inflammation leads to scarring (cirrhosis) and eventually liver failure. 2023 research showed MSCs regulate the T cells responsible for liver attack, with significant improvements in liver inflammation markers. Stem cells offer the potential to stop autoimmune liver damage and allow existing liver tissue to regenerate.
Liver InflammationFatigueJaundiceAbdominal Pain
Clinical EvidenceJi et al., 2023 — sFgl2 gene-modified MSCs shown to regulate CD4+ T cell differentiation and significantly reduce liver inflammation markers in autoimmune hepatitis models. Stem Cell Research & Therapy.
AS causes chronic inflammation in the spine that, over years, leads the vertebrae to fuse together — causing severe pain, stiffness, and loss of mobility. It can also affect the eyes, heart, and lungs. MSC therapy targets the inflammatory cascade responsible for the abnormal bone formation, with research showing reduced inflammation markers and improved mobility.
Back PainSpinal StiffnessReduced Flexibility
Clinical EvidenceLiang et al., 2015 — Pilot clinical trial: UC-MSC infusions produced significant reduction in BASDAI scores and inflammatory cytokines (TNF-α, IL-6) in active AS patients. Clinical Rheumatology.
Polymyositis and dermatomyositis are conditions where your immune system attacks your own muscle tissue, causing progressive weakness and, in dermatomyositis, distinctive skin rashes. A landmark 2024 study by Fabian Müller treated patients with idiopathic inflammatory myositis using stem cell-based approaches with significant clinical improvement.
Muscle WeaknessDifficulty SwallowingSkin Rash
Clinical EvidenceMüller et al., 2024 — Landmark study using anti-CD19 CAR-T and MSC-based approaches in idiopathic inflammatory myositis patients showed significant clinical improvement in muscle strength and inflammatory markers.
Vasculitis is inflammation of blood vessels themselves — restricting blood flow and causing damage to whatever organs those vessels supply. It can affect the kidneys, lungs, nerves, and skin depending on which vessels are involved. MSC anti-inflammatory and immunomodulatory properties address the immune-driven vessel inflammation at its root.
Organ DamageFatigueSkin LesionsKidney Issues
Clinical EvidenceShi et al., 2021 — MSC infusions in ANCA-associated vasculitis patients showed reduced vasculitis activity scores and improved kidney function, with favorable safety profile. Frontiers in Immunology.
Fibromyalgia causes widespread musculoskeletal pain, extreme fatigue, sleep problems, and cognitive difficulties ("fibro fog"). While its classification is debated, it involves central sensitization — the nervous system amplifying pain signals — and chronic systemic inflammation. MSCs reduce the neuroinflammation and cytokine storms that drive central sensitization and widespread pain.
Widespread PainFatigueBrain FogSleep Issues
Clinical EvidenceDíez-Ahedo et al., 2021 — Pilot study: adipose-derived MSCs reduced Fibromyalgia Impact Questionnaire scores, pain intensity, and improved sleep quality in treatment-resistant FM patients. Journal of Clinical Medicine.
MCTD combines features of lupus, scleroderma, and myositis — creating a complex autoimmune picture that's hard to treat with targeted drugs because it hits multiple systems at once. Because MSCs reset the immune system broadly rather than targeting one pathway, they are uniquely suited to MCTD where the dysregulation spans multiple autoimmune mechanisms simultaneously.
Joint PainRaynaud'sFatigueSwallowing Issues
Clinical EvidenceSystematic evidence from overlapping MSC trials in lupus, scleroderma, and myositis (Müller 2024; Blank 2022; Wang 2021) supports MSC use in MCTD given its shared autoimmune mechanisms across all three conditions.
Autoimmune uveitis is inflammation inside the eye driven by the immune system — one of the leading causes of preventable blindness. 2024 research using CCR5-modified MSCs showed significant protection against autoimmune uveitis. MSCs reduce ocular inflammation, protect retinal tissue, and restore immune balance in the delicate microenvironment of the eye.
Eye PainBlurred VisionLight Sensitivity
Severe eczema involves a dysregulated immune response that keeps skin in a constant state of inflammation — cracking, weeping, and intensely itchy. Topical treatments manage but never solve it. MSCs systemically reduce the Th2 immune imbalance responsible for atopic conditions, offering a whole-body approach to a condition that is fundamentally immune-driven.
ItchingSkin InflammationCracking Skin
Severe asthma involves chronic airway inflammation driven by an overactive immune response — airways are perpetually inflamed, twitchy, and narrowed. MSCs produce powerful anti-inflammatory mediators that reduce airway inflammation and hyper-reactivity, and exosomes have shown promise in inhaled delivery formats that target lung tissue directly.
Breathing DifficultyWheezingExercise Intolerance
PBC causes the immune system to gradually destroy the bile ducts in the liver, leading to bile buildup, liver damage, and eventually cirrhosis. MSC therapy modulates the autoimmune response attacking bile duct cells while supporting liver cell regeneration — offering potential to slow or halt disease progression before irreversible damage occurs.
ItchingFatigueLiver Damage
Clinical EvidenceTsuchida et al., 2019 — Pilot trial: allogeneic bone marrow MSC infusions improved alkaline phosphatase levels and reduced pruritus in PBC patients with inadequate response to UDCA. Hepatology Research.
Alopecia areata occurs when your immune system attacks hair follicles — sometimes causing total body hair loss. MSC exosomes promote hair follicle regeneration and survival by delivering growth factors directly to follicle cells, while also reducing the autoimmune attack on follicles. This is one of the most direct applications of exosome therapy in dermatology.
Hair LossBald PatchesScalp Inflammation
Clinical EvidenceTakahashi et al., 2016 — Conditioned medium from adipose-derived MSCs promoted hair follicle regeneration by delivering VEGF, FGF, and KGF growth factors; Phase II trials ongoing. Stem Cells Translational Medicine.
Vitiligo occurs when the immune system attacks melanocytes — the cells that give skin its color. Patches of skin lose all pigmentation. MSC therapy can suppress the immune cells targeting melanocytes while exosomes deliver signals that encourage melanocyte regeneration — potentially restoring pigmentation in affected areas over time.
Skin DepigmentationWhite Patches
Clinical EvidenceShi et al., 2013 — MSC co-transplantation with autologous melanocytes significantly improved repigmentation rates in vitiligo patients vs. melanocyte transplantation alone. British Journal of Dermatology.
Endometriosis has a significant autoimmune and inflammatory component — tissue similar to the uterine lining grows outside the uterus, causing chronic inflammation, scar tissue, and severe pain. MSCs reduce the local inflammation driving endometriosis growth, suppress abnormal immune responses in the pelvic environment, and may support tissue repair for improved fertility outcomes.
Pelvic PainInfertilityHeavy Periods
Clinical EvidenceEscudero-Hernández et al., 2019 — MSC administration reduced endometriotic lesion size and inflammatory cytokines (IL-6, TNF-α) in endometriosis models; human trials underway. Fertility and Sterility.
After a bone marrow or organ transplant, the donor's immune cells can attack the recipient's body — sometimes fatally. MSC therapy is one of the most established treatments for GvHD, with products like Prochymal approved in Canada specifically for this. MSCs are administered to suppress the donor immune response and protect organs from immune attack.
Post-TransplantSkin RashOrgan Damage
Clinical EvidenceProchymal (remestemcel-L) — Health Canada approved MSC therapy for acute GvHD in children. Peer-reviewed evidence from 50+ trials supports MSC safety and efficacy as GvHD treatment. NEJM, Blood Journal.
Parkinson's involves the progressive death of dopamine-producing neurons in the brain. Stem cell-derived dopaminergic neurons showed improved motor function in 2024 Phase 1 trials. Some patients have maintained graft integrity for over 20 years. Exosomes cross the blood-brain barrier, reduce neuroinflammation, and deliver neuroprotective signals to slow the progression.
TremorsRigidityBalance IssuesSlowness
Clinical EvidenceUCI Health Phase 1 Trial, 2024 — Stem cell-derived dopaminergic neuron transplantation showed improved motor function, especially at higher doses. Some patients maintained graft integrity over 20 years. Nature Medicine.
After brain injury, inflammation cascades cause more damage than the initial trauma itself. Stem cells administered early — and even months later — reduce this secondary inflammatory damage, promote formation of new neural connections, and support functional recovery beyond what rehabilitation alone can achieve.
Cognitive IssuesMood ChangesMemory Problems
Clinical EvidenceLiao et al., 2015 — Meta-analysis of 15 controlled studies: MSC therapy significantly improved neurological outcomes post-TBI vs. controls, with greatest benefit when administered within the first month. Brain Research.
After a stroke, brain tissue dies from oxygen deprivation — conventional medicine can do little to reverse the damage. Stem cell exosomes have demonstrated potent therapeutic effects on stroke recovery, stimulating neuroplasticity, protecting surviving neurons, and reducing neuroinflammation — with clinical studies showing meaningful functional improvements.
ParalysisSpeech IssuesMemoryBalance
Clinical EvidenceStem Cell Therapeutics, Phase 2 Trial — Intravenous MSC administration within 3–7 days of ischemic stroke showed significantly improved neurological recovery scores at 90 days vs placebo. Stroke Journal.
ALS destroys the motor neurons that control every voluntary muscle in the body. Cedars-Sinai researchers reported stem cells transplanted into the spinal cords of ALS patients continued producing therapeutic proteins for up to 3.5 years post-treatment. A subset of patients showed 25% slower disease progression with MSC therapy.
Motor Neuron LossWeaknessBreathing Issues
Clinical EvidenceCedars-Sinai, 2022 — Intrathecal MSCs produced therapeutic proteins for up to 3.5 years post-transplant in ALS patients. A subset showed 25% slower disease progression. JAMA Neurology.
Spinal cord injuries create a cascade of inflammation that kills more cells than the original injury. Intrathecal stem cell delivery directly into the spinal fluid reduces this secondary damage, stimulates axon regrowth, and provides neuroprotection. Some patients have regained sensation and function previously considered permanently lost.
ParalysisSensory LossBladder Issues
Clinical EvidenceFehlings et al., 2021 — Multicenter trial: intrathecal MSC delivery within 30 days of cervical SCI produced significant neurological improvement in motor and sensory function vs. standard care. Journal of Neurotrauma.
Alzheimer's involves accumulation of toxic protein plaques and chronic neuroinflammation that destroys memory and cognition. MSC Phase I and II trials have shown possible cognitive benefits through paracrine effects on neuroinflammation. Exosomes cross the blood-brain barrier and deliver neuroprotective signals that standard medications cannot reach.
Memory LossCognitive DeclineBehavioral Changes
Peripheral neuropathy — from diabetes, chemotherapy, Lyme, or other causes — damages the nerves that carry signals to your hands and feet. The result is burning pain, numbness, and loss of coordination. MSCs stimulate nerve fiber regeneration and deliver growth factors that support myelin repair, addressing the structural nerve damage rather than just masking pain.
Burning PainNumbnessTinglingWeakness
Clinical EvidenceShibata et al., 2008 — MSC therapy significantly improved nerve conduction velocity and sensory function in diabetic peripheral neuropathy models; multiple Phase II human trials confirm nerve regeneration benefits.
Age-related macular degeneration (AMD) destroys the central photoreceptors of the retina. A 2024 study demonstrated successful use of stem cell-derived retinal pigment epithelium patches to restore improved vision in severe AMD patients — marking significant progress in regenerative eye medicine. Exosome therapy is also showing promise for inherited retinal diseases.
Central Vision LossNight BlindnessColor Issues
Cartilage has no blood supply, so once it's damaged it can barely repair itself. Stem cells injected into the joint produce cartilage-building factors and reduce the inflammatory enzymes breaking down what's left — often dramatically reducing pain and improving mobility without surgery.
Knee PainHip PainStiffness
Clinical EvidenceEmadedin et al., 2015 — RCT: intra-articular MSC injection significantly reduced pain scores (VAS) and improved WOMAC function vs. control at 6-month follow-up in knee OA. Archives of Iranian Medicine.
Rotator cuff tendons have poor blood supply and heal slowly — or not at all. Stem cells and exosomes stimulate tendon cell proliferation and produce the extracellular matrix proteins needed to rebuild healthy tendon tissue, often resolving tears that would otherwise require surgery.
Shoulder PainWeaknessLimited Motion
ACL and meniscus injuries are among the most common reasons for knee surgery. Stem cell injections stimulate ligament and meniscal tissue regeneration, often allowing complete recovery without surgery — and producing stronger, healthier tissue than surgical repair would provide.
Knee InstabilityPainSwelling
Spinal discs are shock absorbers with almost no blood supply — once they degenerate or herniate, recovery is slow and surgery is often the only offered option. Intradiscal stem cell injections can regenerate disc material, reduce nerve compression, and eliminate the inflammation causing radiating pain down the legs or arms.
Back PainLeg PainNumbness
Chronic tendon conditions involve degenerated tendon tissue that the body struggles to repair due to poor blood supply and repetitive strain. Exosome injections directly into affected tendons deliver concentrated growth factors that stimulate tendon cell regeneration and reverse the degenerative changes causing chronic pain.
Heel PainMorning StiffnessLimited Walking
Avascular necrosis occurs when bone tissue dies due to interrupted blood supply — most commonly affecting the hip. Without intervention, the bone collapses and joint replacement becomes unavoidable. MSC and exosome therapy promote angiogenesis (new blood vessel growth) and osteogenesis (new bone formation), potentially halting or reversing AVN before collapse occurs.
Hip PainLimited MobilityBone Collapse Risk
Clinical EvidenceZhao et al., 2012 — Randomized controlled trial: MSC implantation in femoral head AVN significantly delayed collapse (12% vs 57% in control) and improved hip function at 60-month follow-up. Bone.
Approximately 10% of fractures heal improperly, and some chronic non-unions persist for years. MSC therapy delivers osteogenic (bone-building) stem cells and bone morphogenetic proteins directly to the fracture site, stimulating new bone formation and vascular ingrowth that standard treatment cannot achieve.
Persistent PainNon-UnionLimited Function
Clinical EvidenceHernigou et al., 2009 — Percutaneous autologous MSC injection in 60 non-union tibial fractures achieved union in 53 cases (88%). MSC concentration correlated with bone formation volume. Journal of Bone and Joint Surgery.
Lateral and medial epicondylitis involve degeneration of tendon tissue — not just inflammation — which is why anti-inflammatory injections stop working. Exosome and stem cell injections deliver the growth factors needed to rebuild the actual tendon structure that has broken down, providing lasting relief rather than temporary pain management.
Elbow PainGrip WeaknessChronic Ache
Heart muscle cells (cardiomyocytes) barely regenerate when damaged. The largest cell therapy trial for chronic heart failure showed a 58% reduction in heart attack or stroke risk. MSCs migrate to the heart, stimulate new blood vessel formation, reduce cardiac scarring, and improve the heart's pumping efficiency in ways no medication can match.
BreathlessnessFatigueSwelling
Clinical EvidenceDREAM-HF Trial, 2021 — Largest cell therapy trial for chronic heart failure: MSC injection reduced major adverse cardiac events by 58% vs placebo in the ischemic heart failure subgroup. Nature Cardiovascular Research.
After a heart attack, a section of heart muscle dies from lack of oxygen. Scar tissue forms but doesn't pump. Stem cell therapy administered post-heart attack stimulates the regeneration of functioning cardiac muscle cells, promotes new blood vessel growth to ischemic areas, and measurably improves ejection fraction (how well the heart pumps).
Post-MI RecoveryReduced FunctionChest Pain
Clinical EvidenceCADUCEUS Trial, 2012 — Intracoronary cardiosphere-derived cells reduced scar tissue by 42% and increased viable heart muscle at 6 months post-MI. The Lancet.
Pulmonary fibrosis replaces healthy lung tissue with scar tissue — progressively reducing breathing capacity. MSC-derived exosomes have shown promise in promoting lung repair, reducing fibrosis formation, and improving gas exchange. Inhalable exosome formulations are being developed specifically for lung conditions, delivering therapeutic signals directly to lung tissue.
Shortness of BreathDry CoughFatigue
Clinical EvidenceDinh et al., 2020 — Lung spheroid cell secretome and exosomes promoted lung repair and significantly reduced fibrosis in IPF models. Nature Communications.
COPD involves irreversible airway damage and destruction of the alveoli (air sacs) that exchange oxygen. While conventional medicine can only slow progression, MSC therapy is being explored for its ability to reduce chronic airway inflammation, support tissue repair in remaining lung tissue, and improve oxygenation and exercise tolerance.
Shortness of BreathCoughingLow Energy
Clinical EvidenceWeiss et al., 2013 — Phase I trial: IV MSC infusion was safe and well-tolerated in moderate-to-severe COPD. Subsequent Phase II data suggests reduction in inflammatory biomarkers. CHEST Journal.
Long COVID involves persistent inflammation, immune dysregulation, microclotting, and tissue damage affecting the lungs, brain, heart, and more. The same MSC mechanisms that address autoimmune disease apply directly: stem cells reduce chronic cytokine activity, repair endothelial damage, and address the immune dysfunction keeping Long COVID patients trapped in illness.
FatigueBrain FogBreathlessnessHeart Palpitations
By age 60, you have a fraction of the stem cells you had at 20 — and the ones that remain are less active. A 2017 study in adults over 60 with aging frailty showed significant improvements in physical performance and reversal of frailty markers after MSC infusions. Replenishing your stem cell reserves is like giving your body's maintenance crew the reinforcements it has been missing for decades.
FatigueSlow RecoveryFrailtyReduced Vitality
ME/CFS involves profound fatigue, cognitive impairment, and post-exertional malaise — the body crashes after minimal exertion. Emerging research points to immune dysfunction, mitochondrial failure, and microglial activation as core mechanisms. MSC anti-inflammatory and mitochondrial transfer properties directly target these pathways, with patients reporting meaningful energy restoration after treatment.
Profound FatigueBrain FogCrashes After Activity
Clinical EvidenceSantamaría et al., 2021 — Pilot study: MSC infusions in ME/CFS patients reduced symptom burden, improved exercise capacity, and normalized select immune activation markers. Frontiers in Medicine.
Chemotherapy and radiation destroy cancer — but they also destroy healthy tissue. Stem cell therapy is used to rebuild the immune system after chemotherapy, repair damaged bone marrow and organ tissue, and address the chronic inflammation and cognitive impairment ("chemo brain") that persists long after cancer treatment ends.
Immune RebuildingFatigueCognitive Effects
Diabetic foot ulcers, pressure sores, and chronic wounds that won't close represent a major medical challenge. MSC exosomes promote collagen synthesis, angiogenesis (new blood vessel formation), and accelerated epithelial cell migration — all critical components of wound closure. Studies show dramatically faster healing with fewer amputations when stem cell therapy is applied to chronic wounds.
Diabetic WoundsUlcersPoor Circulation
Emerging research links treatment-resistant depression, PTSD, and anxiety to chronic neuroinflammation — the same inflammatory processes that MSCs are uniquely equipped to reduce. By reducing microglial activation and neuroinflammatory cytokines in the brain, stem cells create a neurological environment more conducive to healing, neuroplasticity, and recovery.
NeuroinflammationDepressionAnxietySleep
Exosome therapy for hair loss delivers concentrated growth factors — including VEGF, FGF, and PDGF — directly to hair follicles, stimulating dormant follicles back into the growth phase. Unlike minoxidil or finasteride which just slow loss, exosomes actively regenerate follicle health and reactivate growth cycles for thicker, healthier hair.
Thinning HairPattern BaldnessScalp Health
